Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04883749
Title Efficacy of Acalabrutinib in Very Old or Frail Patients With Treatment-naïve or Relapsed/Refractory CLL (CLL-Frail)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors German CLL Study Group
Age Groups: adult | senior
Covered Countries DEU | AUT

No variant requirements are available.